Filtered By:
Infectious Disease: Hepatitis C
Drug: Viread

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 104 results found since Jan 2013.

An update on hepatitis B, D, and E viruses.
This article summarizes a presentation by Jennifer Price, MD, at the IAS-USA continuing education program held in San Francisco, California, in June 2013. PMID: 24531556 [PubMed - indexed for MEDLINE]
Source: Topics in antiviral medicine - November 12, 2014 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

Inhibiting the Secretion of Hepatitis B Surface Antigen (HBsAg) to Treat Hepatitis B Infection- a Review.
Conclusion A range of agents (small-molecules, natural products, macrocycles, and non-small molecules) have been described as having the ability to suppress the secretion of HBsAg (in vitro, as well as in vivo in animal models, pre-clinical models, and clinical trials), and this review will focus on an overview of the different agents, and different strategies being pursued to develop methods of inhibiting the secretion of HBsAg, with a view to the cure of HBV. PMID: 28056752 [PubMed - as supplied by publisher]
Source: Infectious Disorders Drug Targets - January 3, 2017 Category: Infectious Diseases Authors: Baugh SD Tags: Infect Disord Drug Targets Source Type: research

Safety considerations in the management of hepatitis C and HIV co-infection
Expert Opin Drug Saf. 2023 Apr 25. doi: 10.1080/14740338.2023.2206647. Online ahead of print.ABSTRACTINTRODUCTION: Both HCV and HIV are highly prevalent infections with current estimates of 57 and 38 million people infected worldwide, respectively. Oral antivirals can be curative for HCV and rescue HIV patients from disease progression. Dual therapy in coinfected patients requires expertise.AREAS COVERED: Four major issues challenge dual HCV and HIV treatment, including overlapping drug-related side effects, hepatitis B reactivation, immune reconstitution inflammatory syndromes (IRIS) and drug-drug interactions (DDI). A se...
Source: Expert Opinion on Drug Safety - April 25, 2023 Category: Drugs & Pharmacology Authors: Vicente Soriano V íctor Moreno-Torres Ana Trevi ño Pablo Barreiro Fernando de Jesus Octavio Corral Carmen de Mendoza Source Type: research

Viral hepatitis in persons living with HIV in the post-COVID era
AIDS Rev. 2023;25(1):1-13. doi: 10.24875/AIDSRev.M23000061.ABSTRACTCoinfection with hepatitis viruses A to E is frequent in persons living with HIV (PLWH) and causes significant morbidity and mortality. Oro-fecal transmissible hepatitis A and E mostly produce acute self-limited episodes in poor income regions and in non-vaccinated travelers. In high-income countries, outbreaks of hepatitis A occur in men having sex with men (MSM) and chronic hepatitis E is occasionally reported among PLWH with severe immunodeficiency. Chronic hepatitis B, C, and D are frequent in PLWH in highly endemic regions and globally in persons who i...
Source: AIDS Reviews - March 23, 2023 Category: Infectious Diseases Authors: Vicente Soriano V íctor Moreno-Torres Carmen de Mendoza Octavio Corral Pablo Barreiro Source Type: research